Financials

  • Market Capitalization 592.45 M
  • Employee 371
  • Founded 2008
  • CEO N/A
  • Website www.regenxbio.com
  • Headquarter Maryland, United States
  • FIGI BBG007Z9V591
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.5
市销率
4.93

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2781
RLMD
Relmada Therapeutics, Inc. - Common Stock
5.87 USD-5.48%-8.85%-10.38%+862.30%615.71 M USD
2788
NGNE
Neurogene Inc. - Common Stock
37.91 USD-3.90%-5.81%+27.64%+28.86%599.05 M USD
2791
TECX
Tectonic Therapeutic, Inc. - Common Stock
31.85 USD-2.00%-9.49%+5.95%+85.71%600.98 M USD
2795
FDMT
4D Molecular Therapeutics, Inc. - Common Stock
11.12 USD-4.79%-13.60%+26.36%-1.59%581.31 M USD

新闻